Nitinol-based Medical Devices Market 2017 - Boston Scientific Corporation, Abbott Laboratories, Medtronic, Terumo Corporation, B.Braun Melsungen AG, C.R. Bard, Arthrex Inc., Zimmer Biomet Holdings Inc., Cook Medical, MICRO-TECH and others.

Global market trend:

The global nitinol-based medical devices market is expected to reach USD 26.5billion by 2027, growing at a CAGR of 8.6% from 2017 – 2027. Factors such as increasing application of nitinol-based medical devices for wide range of diseases, and growing innovation in the field of minimally invasive surgeries is boosting the growth of the market. Additionally, with the rising geriatric population, as well as growing need of people to access quality healthcare, the demand for advanced material like nitinol is expected to result in continued progress of the market.

Request a Free Sample Copy of the Report Here:

https://goo.gl/MXvLdk

Segment Analysis:
Based on product, the global nitinol-based medical devices market has been segmented intostents, guidewires, catheter shafts, needles, retrieval baskets, others.Stents are expected to occupy the largest share in the global market owing to itsunique characteristic properties of superelasticity and stress hysteresis. Furthermore, the kink resistance quality of nitinol is well-suited for the winding vessel pathways of peripheral arteries, thereby increasing its popularity in the application of stents.
Based on application, the nitinol-based medical devices market has been categorized into orthopedic, vascular, gastroenterology, dental, others. Vascular application dominated the segment in 2016 due to increasing prevalence of cardiovascular diseases globally, and growing geriatric population. In addition, nitinol is majorly used for the manufacturing of stents which are in turn adopted for the management of peripheral artery diseases.

Geographical Analysis:
Based on geography, the nitinol-based medical devices market has been segmented into North America, Europe, Asia Pacific, Latin America and Rest of the World. North America is dominating the global market specifically due to increasing preference for minimally invasive procedures and lucrative reimbursement policies for stenting processes.

Asia Pacific is expected to expand at the highest growth rate. Factors such as increased number of population affected with peripheral artery diseases, growing innovation in manufacture of stents and guidewires, and increasing application of nitinol for orthopaedic implants is contributing towards the growth of the market in Asia Pacific.

Browse the full Report here:

https://www.1marketresearch.com/market-reports/nitinol-based-medical-devices-market-125294/

Key Market Players:

Key market players operating in the global nitinol-based medical devices market are Boston Scientific Corporation, Abbott Laboratories, Medtronic, Terumo Corporation, B.Braun Melsungen AG, C.R. Bard, Arthrex Inc., Zimmer Biomet Holdings Inc., Cook Medical, MICRO-TECH and others.
Segments Covered:

• Product Segment (Revenue, USD Billion, 2015 – 2027)
• Stents
• Guidewires
• Catheter shafts
• Needles
• Retrieval baskets
• Others

Application Segment (Revenue, USD Billion, 2015 – 2027)
• Orthopedic
• Vascular
• Gastroenterology
• Dental
• Others

End-user Segment (Revenue, USD Billion, 2015 – 2027)
• Hospitals & Clinics
• Surgery centers
• Others

Regional Segment (Revenue, USD Billion, 2015 – 2027)
• North America
o U.S.
o Canada
• Europe
o U.K.
o Germany
o France
• Asia Pacific
o Japan
o China
o India
• Latin America
o Brazil
o Mexico
• MEA
o South Africa

About Us:

1MarketResearch is a global business market research providing syndicated research Report, customized research reports, company profiles and industry databases across multiple domains.
We provide intellectual, precise and meaningful data at a lightning speed.
We host more than 500,000 Industry research products.

Contact US:

1MarketResearch
304, S. Jones Blvd, #3299,
Las Vegas, NV - 89107
USA : +1 702-425-8599
Email : Sales@1MarketResearch.com
Web : www.1MarketResearch.com

This release was published on openPR.